Evidence map›Paper›PMID 30618601›Full record

ArticleFrontiers in molecular neuroscience2018

MicroRNA-22 Controls Aberrant Neurogenesis and Changes in Neuronal Morphology After Status Epilepticus.

Edward H Beamer, Jeronimo Jurado-Arjona, Eva M Jimenez-Mateos, James Morgan, Cristina R Reschke, Aidan Kenny, Gioacchino de Leo, Luis A Olivos-Oré, Marina Arribas-Blázquez, Stephen F Madden and 11 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Small Differences and Big Changes: The Many Variables of MicroRNA Expression and Function in the Brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  6. The role of dendritic spines in epileptogenesis.Frontiers in cellular neuroscience · 2023
    Review
  7. Article
  8. Review
  9. Analyzing the Role of the P2X7 Receptor in Epilepsy.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Article
  11. Review
  12. Exploring with [Molecular imaging and biology · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Edward H BeamerDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Jeronimo Jurado-ArjonaInstitute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Eva M Jimenez-MateosDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
James MorganDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Cristina R ReschkeDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Aidan KennyDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Gioacchino de LeoDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Luis A Olivos-OréDepartment of Pharmacology and Toxicology, Veterinary Faculty, Instituto Universitario de Investigación en Neuroquímica, Universidad Complutense de Madrid, Madrid, Spain.
Marina Arribas-BlázquezDepartment of Pharmacology and Toxicology, Veterinary Faculty, Instituto Universitario de Investigación en Neuroquímica, Universidad Complutense de Madrid, Madrid, Spain.
Stephen F MaddenData Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
Jesús Merchán-RubiraDepartment of Molecular Biology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid (UAM), Centro Investigación Biomédica en Red Enfermedades Neurodegenerativa (CIBERNED), Madrid, Spain.
Norman DelantyFutureNeuro Research Centre, RCSI, Dublin, Ireland.
Michael A FarrellBeaumont Hospital, Dublin, Ireland.
Donncha F O'BrienBeaumont Hospital, Dublin, Ireland.
Jesus AvilaDepartment of Molecular Biology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid (UAM), Centro Investigación Biomédica en Red Enfermedades Neurodegenerativa (CIBERNED), Madrid, Spain.
Miguel Diaz-HernandezDepartment of Biochemistry and Molecular Biology, Veterinary Faculty, Universidad Complutense de Madrid, Madrid, Spain.
M Teresa Miras-PortugalDepartment of Biochemistry and Molecular Biology, Veterinary Faculty, Universidad Complutense de Madrid, Madrid, Spain.
Antonio R ArtalejoDepartment of Pharmacology and Toxicology, Veterinary Faculty, Instituto Universitario de Investigación en Neuroquímica, Universidad Complutense de Madrid, Madrid, Spain.
Felix HernandezDepartment of Molecular Biology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid (UAM), Centro Investigación Biomédica en Red Enfermedades Neurodegenerativa (CIBERNED), Madrid, Spain.
David C HenshallDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Tobias EngelDepartment of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Royal College of Surgeons in Ireland · IEUniversidad Complutense de Madrid · ESBeaumont Hospital · IECentro de Biología Molecular Severo Ochoa · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prolonged seizures (status epilepticus, SE) may drive hippocampal dysfunction and epileptogenesis, at least partly, through an elevation in neurogenesis, dysregulation of migration and aberrant dendritic arborization of newly-formed neurons. MicroRNA-22 was recently found to protect against the development of epileptic foci, but the mechanisms remain incompletely understood. Here, we investigated the contribution of microRNA-22 to SE-induced aberrant adult neurogenesis. SE was induced by intraamygdala microinjection of kainic acid (KA) to model unilateral hippocampal neuropathology in mice. MicroRNA-22 expression was suppressed using specific oligonucleotide inhibitors (antagomir-22) and newly-formed neurons were visualized using the thymidine analog iodo-deoxyuridine (IdU) and a green fluorescent protein (GFP)-expressing retrovirus to visualize the dendritic tree and synaptic spines. Using this approach, we quantified differences in the rate of neurogenesis and migration, the structure of the apical dendritic tree and density and morphology of dendritic spines in newly-formed neurons.SE resulted in an increased rate of hippocampal neurogenesis, including within the undamaged contralateral dentate gyrus (DG). Newly-formed neurons underwent aberrant migration, both within the granule cell layer and into ectopic sites. Inhibition of microRNA-22 exacerbated these changes. The dendritic diameter and the density and average volume of dendritic spines were unaffected by SE, but these parameters were all elevated in mice in which microRNA-22 was suppressed. MicroRNA-22 inhibition also reduced the length and complexity of the dendritic tree, independently of SE. These data indicate that microRNA-22 is an important regulator of morphogenesis of newly-formed neurons in adults and plays a role in supressing aberrant neurogenesis associated with SE.

Indexed as

epilepsymicroRNA-22mouse modelneurogenesisstatus epilepticus

Identifiers

PMID30618601
PMCPMC6298134
OpenAlexW2904787560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.